Total Liabilities Summary of Haw Par Corporation Limited

Haw Par Corporation Limited's latest annual total liabilities in 2023 was 117.17 Million SGD , up 15.55% from previous year.
Haw Par Corporation Limited's latest quarterly total liabilities in 2024 Q2 was 120.11 Million SGD , down 0.0% from previous quarter.
Haw Par Corporation Limited reported annual total liabilities of 101.4 Million SGD in 2022, up 40.68% from previous year.
Haw Par Corporation Limited reported annual total liabilities of 72.08 Million SGD in 2021, up 12.63% from previous year.
Haw Par Corporation Limited reported quarterly total liabilities of 120.11 Million SGD for 2024 Q1, up 2.51% from previous quarter.
Haw Par Corporation Limited reported quarterly total liabilities of 117.17 Million SGD for 2023 FY, up 15.55% from previous quarter.

Annual Total Liabilities Chart of Haw Par Corporation Limited (2023 - 2001)

Historical Annual Total Liabilities of Haw Par Corporation Limited (2023 - 2001)

Year	Total Liabilities	Total Liabilities Growth
2023	117.17 Million SGD	15.55%
2022	101.4 Million SGD	40.68%
2021	72.08 Million SGD	12.63%
2020	64 Million SGD	-24.55%
2019	84.82 Million SGD	-17.17%
2018	102.41 Million SGD	-45.13%
2017	186.66 Million SGD	16.23%
2016	160.6 Million SGD	2.1%
2015	157.29 Million SGD	-5.71%
2014	166.82 Million SGD	37.59%
2013	121.25 Million SGD	3.36%
2012	117.31 Million SGD	21.44%
2011	96.6 Million SGD	4.15%
2010	92.75 Million SGD	-0.66%
2009	93.37 Million SGD	14.05%
2008	81.86 Million SGD	-20.86%
2007	103.45 Million SGD	9.37%
2006	94.58 Million SGD	25.11%
2005	75.6 Million SGD	79.55%
2004	42.1 Million SGD	-68.87%
2003	135.27 Million SGD	-26.0%
2002	182.8 Million SGD	-12.52%
2001	208.97 Million SGD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	120.11 Million SGD	0.0%
2024 Q1	120.11 Million SGD	2.51%
2023 FY	117.17 Million SGD	15.55%
2023 Q2	109.9 Million SGD	0.81%
2023 Q3	116.41 Million SGD	5.92%
2023 Q1	109.02 Million SGD	7.51%
2023 Q4	117.17 Million SGD	0.65%
2022 Q1	86.55 Million SGD	20.07%
2022 Q4	101.4 Million SGD	0.91%
2022 FY	101.4 Million SGD	40.68%
2022 Q3	100.49 Million SGD	14.84%
2022 Q2	87.5 Million SGD	1.1%
2021 Q3	71.19 Million SGD	10.16%
2021 FY	72.08 Million SGD	12.63%
2021 Q2	64.62 Million SGD	1.5%
2021 Q4	72.08 Million SGD	1.26%
2021 Q1	63.67 Million SGD	-0.52%
2020 Q4	64 Million SGD	1.38%
2020 FY	64 Million SGD	-24.55%
2020 Q2	107.97 Million SGD	0.77%
2020 Q3	63.12 Million SGD	-41.54%
2020 Q1	107.15 Million SGD	26.32%
2019 Q4	84.82 Million SGD	-17.62%
2019 Q2	102.6 Million SGD	0.46%
2019 Q3	102.97 Million SGD	0.36%
2019 Q1	102.12 Million SGD	-0.28%
2019 FY	84.82 Million SGD	-17.17%
2018 Q2	96.93 Million SGD	1.55%
2018 Q3	98.61 Million SGD	1.74%
2018 Q4	102.41 Million SGD	3.86%
2018 Q1	95.45 Million SGD	-48.86%
2018 FY	102.41 Million SGD	-45.13%
2017 FY	186.66 Million SGD	16.23%
2017 Q4	186.66 Million SGD	6.17%
2017 Q3	175.82 Million SGD	1.01%
2017 Q2	174.07 Million SGD	5.01%
2017 Q1	165.77 Million SGD	3.22%
2016 Q1	152.43 Million SGD	-3.09%
2016 Q2	157.72 Million SGD	3.47%
2016 Q3	160.37 Million SGD	1.68%
2016 Q4	160.6 Million SGD	0.15%
2016 FY	160.6 Million SGD	2.1%
2015 Q2	168.05 Million SGD	0.39%
2015 FY	157.29 Million SGD	-5.71%
2015 Q4	157.29 Million SGD	-0.58%
2015 Q3	158.21 Million SGD	-5.86%
2015 Q1	167.4 Million SGD	0.35%
2014 FY	166.82 Million SGD	37.59%
2014 Q1	156.5 Million SGD	29.07%
2014 Q4	166.82 Million SGD	12.38%
2014 Q3	148.44 Million SGD	-5.48%
2014 Q2	157.06 Million SGD	0.36%
2013 Q2	118.07 Million SGD	-1.33%
2013 Q1	119.66 Million SGD	2.0%
2013 Q4	121.25 Million SGD	1.22%
2013 Q3	119.79 Million SGD	1.46%
2013 FY	121.25 Million SGD	3.36%
2012 FY	117.31 Million SGD	21.44%
2012 Q1	100.59 Million SGD	4.13%
2012 Q2	103.44 Million SGD	2.83%
2012 Q3	114.69 Million SGD	10.88%
2012 Q4	117.31 Million SGD	2.29%
2011 Q3	101.67 Million SGD	7.52%
2011 Q1	92.15 Million SGD	-0.64%
2011 Q2	94.55 Million SGD	2.61%
2011 Q4	96.6 Million SGD	-4.98%
2011 FY	96.6 Million SGD	4.15%
2010 Q1	88.26 Million SGD	-5.47%
2010 Q3	85.26 Million SGD	-4.96%
2010 Q2	89.7 Million SGD	1.63%
2010 FY	92.75 Million SGD	-0.66%
2010 Q4	92.75 Million SGD	8.79%
2009 FY	93.37 Million SGD	14.05%
2009 Q4	93.37 Million SGD	0.0%
2008 FY	81.86 Million SGD	-20.86%
2007 FY	103.45 Million SGD	9.37%
2006 FY	94.58 Million SGD	25.11%
2005 FY	75.6 Million SGD	79.55%
2004 FY	42.1 Million SGD	-68.87%
2003 FY	135.27 Million SGD	-26.0%
2002 FY	182.8 Million SGD	-12.52%
2002 Q4	182.8 Million SGD	0.0%
2002 Q2	189.4 Million SGD	0.0%
2001 FY	208.97 Million SGD	0.0%

Peer Total Liabilities Comparison of Haw Par Corporation Limited

Name	Total Liabilities	Total Liabilities Difference
AstraZeneca PLC	61.86 Billion USD	99.811%
Bristol-Myers Squibb Company PFD CONV 2	65.67 Billion USD	99.822%
CSPC Pharmaceutical Group Limited	1.53 Billion USD	92.39%
Clarus Therapeutics Holdings, Inc.	67.62 Million USD	-73.267%
Novartis AG	53.19 Billion USD	99.78%
PT Kalbe Farma Tbk.	255.94 Million USD	54.218%

Global Stocks Search

Haw Par Corporation Limited (HAWPF)

Total Liabilities Summary of Haw Par Corporation Limited

Annual Total Liabilities Chart of Haw Par Corporation Limited (2023 - 2001)

Historical Annual Total Liabilities of Haw Par Corporation Limited (2023 - 2001)

Peer Total Liabilities Comparison of Haw Par Corporation Limited